Retinoblastoma is a malignant intraocular tumor that primarily affects small children. These tumors are primitive neuroectodermal malignancies, however some of them show morphologic evidence of differentiation into photoreceptors. Phototransduction cascades are a series of biochemical reactions that convert a photon of light into a neural impulse in rods and cones. The components of these cascades are uniquely expressed in photoreceptors and, although functionally similar, distinct components of these cascades are expressed in rods and cones. Using HPLC anion exchange chromatography, Western blot analysis, and specific monoclonal and polyclonal antibodies, we found that the cone but not the rod cGMP phosphodiesterase is functionally expressed in all six primary retinoblastomas examined and in three continuous retinoblastoma cell lines. Morphologic evidence of differentiation did not correlate with the expression of the enzyme. Furthermore, GTP analogues could activate the phosphodiesterase activity suggesting that an intact phototransduction cascade is present in the tumors. The presence of the cone phototransduction cascade in retinoblastoma confirms that this tumor has biochemically differentiated along the cone cell lineage. (J. Clin.
Introduction
Retinoblastoma is an intraocular tumor that primarily affects small children (1) and has been found to exist in both inherited and sporadic forms. The inherited form is autosomal dominant, is usually presented bilaterally, and has been correlated with an alteration on the long arm ofthe 13th chromosome (2, 3) . Genetic abnormalities have been associated with both forms (4-7) and a gene in the retinoblastoma locus has been cloned (8) .
Light activates a photoreceptor photopigment and initiates a biochemical cascade which results in the hyperpolarization ofthe photoreceptor membrane (9) . Some of the various components of the phototransduction cascades have recently been isolated and similar but not identical proteins have been found in rods and cones. Rhodopsin is the light receptor in rods (10) while the blue, red, and green photopigments are the light receptors in cones (1 1, 12) . These receptors, when activated by a photon of light, allow a GTP-GDP exchange to occur on rod and cone GTP-binding proteins (transducins) (13) . GTPtransducin in turn can activate a rod or cone cGMP phosphodiesterase that results in the rapid hydrolysis ofcGMP to GMP (14, 15) . The decreased level of cGMP directly closes a cGMP-gated cation channel in both rods and cones and results in the hyperpolarization of the cell (16) (17) (18) (19) (20) (21) .
The cone phosphodiesterase is separable from the rod phosphodiesterase using anion exchange HPLC (15, 22) and has recently been purified to homogeneity (23) . Monoclonal antibodies prepared to the photoreceptor phosphodiesterases have demonstrated the existence of both common and unique epitopes on the cone and rod isoforms (15, 24) . These antibodies were used to immunocytochemically localize these enzymes in cones and rods (15, 24) . The cone enzyme is probably a homodimer with an apparent subunit molecular mass of 92 kD (15, (22) (23) (24) . The rod enzyme contains two apparent subunits of 88 and 84 kD, respectively (14) . Both isozymes are associated with low molecular mass inhibitory subunits (14, 23, 25) .
The mRNAs for the red and green photopigments and the cone transducin but not for their rod counterparts have been detected in retinoblastoma cell lines (26) . The demonstration of functional expression in retinoblastoma of one or more components of the cone-specific cascade would further confirm that the tumor evolved along the cone cell lineage. Portions of six retinoblastomas as well as several tumor-derived cell lines have been examined and have been found to express enzymatically active cone but not rod phosphodiesterase. This phosphodiesterase can be activated by an endogenous GTPbinding protein indicating that a functional phototransduction cascade related to that found in normal cones is expressed in these tumors.
Methods
Retinoblastomas were obtained from patients undergoing enucleation for the diagnosis and treatment of their disease at Texas Children's Hospital, Houston, TX. The tumors were protected from light using aluminum foil and stored frozen in liquid nitrogen. Human retinas from cadavers were obtained from the Lion's Eye Bank (Houston, TX). Bovine retinas were obtained frozen from Hormel (Omaha, NE). ROS-1, a monoclonal antibody that specifically recognizes the rod and cone phosphodiesterases (15, 24) , and ACC, a monoclonal antibody that specifically recognizes calmodulin (CaM)' (27) , were gifts from Dr. Joe Beavo, University of Washington. CaM isolated as the protein product of a chicken CaM cDNA expressed in a bacterial system (28) was a gift from Dr. Anthony Means, Baylor College of Medicine. Cell lines were grown in the dark as previously described (29) .
All subsequent operations were undertaken using room light. Samples were prepared for and run on anion exchange HPLC by a modification of a method previously described (15) . Each Immunoadsorptions and phosphodiesterase assays were performed in room light as previously described (24, 27) . 100 Mil rabbit antimouse IgG, (Miles Laboratories Inc., Naperville, IL) and 100 Ml of ascites fluid containing the monoclonal antibody ROS-l (at least 1 mg/ml) were sequentially coupled to 1-ml formalin-fixed Staphylococcus aureus. The antibody-coupled cells were washed by centrifugation. The monoclonal antibody ACC was coupled directly to Staphylococcus aureus. 25 Ml of these cells were incubated with the fractions containing phosphodiesterase in a total volume of 100 Ml for 2 h. The samples were centrifuged in a microfuge (Fisher Scientific Co., Pittsburgh, PA) for 2 min and the supernatants assayed for phosphodiesterase activity at 30 First , an excess ofpurified phosphodiesterase was allowed to hydrolyze all of the cyclic nucleotide in the assay. The assay was completed as described above and the results expressed as a percentage of the total cpm in the assay. If the results were < 90% recovery of the nucleoside, the assay was repeated. The recovery of nucleoside from each column was monitored by eluting the columns with 0.5 M NaCl and counting the samples on the scintillation counter as described above. If these results when added to the results of the assay indicated < 90% recovery of nucleoside, the assays were repeated.
The rod and cone outer segment phosphodiesterases and 61 kD CaM-dependent phosphodiesterase were initially purified as previously described (24, 32) . The rod and cone outer segment phosphodiesterases were further purified by anion exchange HPLC using a Mono Q (Pharmacia Fine Chemicals) column as described above. The CaM-dependent phosphodiesterase was further purified by anion exchange HPLC using a TSK DEAE SPW (Toya Soda) column using the same NaCl gradient and buffers as the rod outer segment enzyme.
The tumor was prepared for Western blot analysis by homogenizing in 1 ml 10 mM Tris/HCl, pH 7.5, 1 mM DTT, 150 mM NaCl, 200 MM PMSF, and 1% Triton X-100 and centrifuging as described previously (24) . Half of the resulting extract was applied to ethanolamine-blocked CNBr-activated agarose and the other half to ROS-1 coupled to CNBr-activated agarose prepared as previously described (15) . The samples were incubated at 40C for 2 h on a rotator, washed twice in 10 mM Tris/HCl, pH 7.5, 150 mM NaCl and once in 10 mM Tris/HCl, pH 7.5, in a microfuge, and then eluted with 8 M urea. Samples were electrophoresed in SDS on a 15% total acrylamide, 0.08% bisacrylamide gel as previously described (14, 15) . The gel was blotted onto nitrocellulose at 30 V for 6 h, blocked with 3% casein and probed with a monospecific antisera (Dr. Richard Lolley, Veterans Administration Hospital, Sepulveda, CA) directed to the bovine rod phosphodiesterase (33) . The signal was developed using a Protoblot kit (Promega Biotec, Madison, WI) as specified in the manufacturer's instructions.
Results
The results of a typical anion exchange HPLC cGMP phosphodiesterase profile using a normal human retina are depicted in Fig. 1 A. Enzyme assays were performed in the presence or absence of histone, a protein that has been shown to activate both rod and cone phosphodiesterases (22, 30, 31) . At least four heterogeneous peaks of cGMP phosphodiesterase activity that could be activated by histone were found in agreement with previously described results (15) . Investigations have previously established that the first peak of activity (fractions 39-42; 18% of the total activity in the profile shown in Fig. 1 A) was derived from cones while the activity observed in the latter fractions (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) (62) ; 68% of the activity) was derived from rods (15, 22, 24) . The remaining activity can be immunoadsorbed by an antibody to CaM, can be activated in the presence of calcium and CaM, and appears to have characteristics similar to the CaM-dependent phosphodiesterases derived from brain (27) . The enzyme HPLC profiles were highly reproducible and no other tissue has been found to contain the photoreceptor-derived isozymes (30) . Similar activities observed in tumors would therefore be suspected of being of photoreceptor origin.
Retinoblastomas were obtained from patients who were undergoing diagnostic and therapeutic enucleation. The tissue was grossly and histologically determined to be free of normal retina. The tissue was subjected to the same examination of phosphodiesterase activity as described above. In this profile ( Fig. 1 B) , a prominent peak of histone-stimulated cGMP phosphodiesterase activity was found in the same fractions as the cone phosphodiesterase from a normal human retina. No activity was found in the fractions in which the rod enzyme would have been expected (fractions 52-62).
To verify that this histone-stimulated phosphodiesterase activity was derived from photoreceptors, the rod and cone phosphodiesterase antibody (ROS-1) (15, 22, 24) was used to immunotitrate the enzyme activity (Fig. 1 C) . The antibody reacted with 86% of the activity found in the profile. A monoclonal antibody (ACC) (27) to CaM immunoadsorbed the remaining phosphodiesterase activity in the presence of 100 nM CaM and 0.5 mM CaCl2 (Fig. 1 D) suggesting that 14% of the activity can be accounted for by CaM-dependent phosphodiesterases. These activities could be stimulated by either histone or CaM (Fig. 1 E) . This finding suggested that a CaM-dependent, histone activatable phosphodiesterase eluted in similar fractions as the photoreceptor enzyme on the HPLC profile. Three CaM-dependent phosphodiesterase isozymes have previously been shown to be separated by TSK-DEAE HPLC anion exchange chromatography (34) . When an extract from bovine brain was applied to the Mono Q column and eluted with an identical gradient, the two CaM-dependent isozymes present in this tissue were found in fractions 38-41 and 43-46. There are no ROS-1 immunoadsorbed phosphodiesterase isozymes in brain. Furthermore, when purified bovine brain 61 kD CaM-dependent phosphodiesterase was assayed in the presence of increasing concentrations of histone and compared to the activity from purified rod outer segment phosphodiesterase also assayed in the presence of histone, a Cone Phototransduction in Retinoblastoma similar activation curve was demonstrated for both enzymes (Fig. 2) . Since proteolysis has already been demonstrated to activate both isozymes (25, 35) , immunotitration and anion exchange HPLC analysis must be used concurrently to verify the presence of the cone photoreceptor isozyme.
To verify that the phosphodiesterase was the cone isozyme, the subunit molecular mass of the ROS-1 immunoadsorbed cGMP phosphodiesterase was examined using Western blot analysis with a monospecific polyclonal antisera (33) to the photoreceptor phosphodiesterase. Extracts were prepared from a detergent-solubilized retinoblastoma and immunoadsorbed with ROS-1 coupled to agarose or with agarose alone. The eluted protein from the agarose was subjected to Western blot analysis using the antisera as a specific probe (Fig. 3) . Bovine cone and rod phosphodiesterase enzymes served as controls. The antisera reacted with the immunopurified cone as well as the rod isozymes. This was an expected result since both the rod and cone isoforms share a common epitope recognized by ROS-1. Greater than 95% of the histone-stimulated cGMP phosphodiesterase activity was removed from the retinoblastoma extract by ROS-1. In the lane containing the ROS-1 immunoadsorbed extract, a single polypeptide of -92 kD that appeared to comigrate with the bovine cone phosphodiesterase and which was distinct from the bovine rod isozyme was observed. No labeled polypeptides were observed in the lane containing the agarose adsorbed extract indicating that the immunoadsorption was specific. Therefore, the cone and not the rod phosphodiesterase protein was present in the primary retinoblastomas.
Using the HPLC analysis and antibody immunoadsorption techniques described above, the cone but not the rod phosphodiesterase has been found in all six retinoblastomas so far examined. The CaM-dependent phosphodiesterase was also present in varying amounts in these tumors. The results of these experiments are summarized in Table I. Five continuous cell lines derived from retinoblastomas 100-- as substrate. Total activity was defined as the activity assayed after trypsin proteolysis for the photoreceptor phosphodiesterase and in the presence of calcium and calmodulin for the calmodulin-dependent phosphodiesterase. (26) have been examined for cGMP phosphodiesterase activity using the HPLC methodology and enzyme activity assays described above. The results of these experiments are also summarized in Table I . The cone phosphodiesterase was found in three of these cultures. The CaM-dependent phosphodiesterase was also found in varying amounts in these cultures. The phosphodiesterases were found to be present but with approximately one to two orders of magnitude less specific activity than found in the primary tumors.
The presence of the cone transducin and red-green pigment mRNA but not the rod transducin or rhodopsin mRNA has been previously demonstrated in seven retinoblastoma cell lines (26) . To demonstrate the presence of the functional phototransduction cascade in the cell line, the nonhydrolyzable GTP analogue 5'guanylylimidodiphosphate (GppNHp) was added to a homogenate prepared from the RBLA22 cell line and the homogenate was assayed for cGMP phosphodiesterase activity (Table II) . A significant elevation of activity was demonstrated in the presence of GppNHp suggesting that the cone transducin is functionally expressed and can interact with the cone phosphodiesterase in a GTP-dependent manner. The presence ofcalcium/CaM also produced an increase in activity as would be predicted from the immunotitration analysis of the HPLC profile for this cell line (Table I) . Similar results have been obtained using the RBLA 12 and RBLA28 cell lines as well as with a sample of fresh tumor. When purified activated GCa, Gia, Goa, or Gka (provided by Dr. Lutz Birn- baumer, Baylor College of Medicine) was added to purified rod outer segment phosphodiesterase either in the presence or absence of urea-treated outer segment membranes (36), no activation of phosphodiesterase activity was found. As expected, activation of the phosphodiesterase did occur in the presence of urea treated outer segment membranes and purified rod transducin (TR,). Therefore, the activation of the phosphodiesterase activity observed in the retinoblastoma cell lines implies that the cone transducin and not another GTP binding protein is responsible for the activation of the cone phosphodiesterase activity. These results strongly suggest that the members of the cone phototransduction cascade, whose mRNAs have previously been shown to be present (26) , are expressed in a functional form.
Discussion
Phototransduction, the mechanism that converts an adsorbed photon oflight into a neural impulse, is a series ofbiochemical 92 kD --88/84 kD A B C D Figure 3 . Western blot analysis of the photoreceptor phosphodiesterase in retinoblastoma. The tumor was prepared for Western blot analysis by homogenizing in 1 ml 10 mM Tris/HCl, pH 7.5, 1 mM DTT, 150 mM NaCl, 200 AM PMSF, and 1% Triton X-100 and centrifuging as described previously (24) . Half of the resulting extract was applied to ethanolamine-blocked CNBr-activated agarose and the other half to ROS-I coupled to CNBr-activated agarose that had been prepared as previously described (15) . Samples containing bovine cone or rod phosphodiesterase (see Methods) were similarly purified by immunoadsorption with ROS-1. The samples were incubated at 4°C for 2 h on a rotator, washed twice in 10 mM Tris/HCI, pH 7.5, 150 mM NaCI and once in 10 mM Tris/HCI, pH 7.5, in a microfuge, and then eluted with 8 M urea. Samples were electrophoresed in SDS on a 15% total acrylamide, 0.08% bisacrylamide gel as previously described (14, 15) . The gel was blotted onto nitrocellulose at 30 V for 6 h, blocked with 3% casein and probed with a monospecific antisera (Dr. Richard Lolley, Veterans Administration Hospital, Sepulveda, CA) directed to the bovine rod phosphodiesterase (33) . The signal was developed using a Protoblot kit (Promega Biotec reactions that result in the light-activated hydrolysis of the second messenger cGMP (37) . The decrease in this cyclic nucleotide results in the closure of a cGMP-gated cation channel and the hyperpolarization of the cell (38) . This biochemical process takes place exclusively in photoreceptors. This cell type has only been found in the retina and the pineal gland (39). No other tissue source of these enzymes has been observed (30, 40) .
Two principal types of photoreceptors exist in the retina: the rod and the cone. In the human retina, the rod is the predominant photoreceptor and is present throughout the retina (41) . The rod is more sensitive to light and is able to respond to a single photon (42, 43 Monoclonal antibody was coupled to Staphylococcal aureus as previously described (see Methods), incubated with aliquots of each fraction obtained from anion exchange HPLC profiles as described in Fig. 1 , and the centrifuged supernatants were assayed for cGMP phosphodiesterase activity in the presence of 2 mg/ml histone using 10 MM [3H]cGMP as substrate. The total activity left by each antibody was quantitated in each profile using a computer program based on the cubic spline integration function (55) and expressed as a percentage of the total activity in the profile. The total activity (nmol/min X g tissue) was similarly measured in the fractions of the HPLC profile after incubation with Staphylococcus aureus without antibody. ROS-l is a monoclonal antibody that interacts exclusively with rod and cone outer segment cGMP phosphodiesterases (15, 24) . ACC is a monoclonal antibody that interacts with CaM and with CaM bound to the calmodulin-dependent phosphodiesterases in the presence of calcium (27) . The percentage recovery refers to the total activity recovered from the HPLC profile as compared to the total activity injected into the HPLC. * A small peak of activity found after ROS-1 immunoadsorption and stimulation by calcium-CaM accounted for -2% of the activity in the profile. color vision (12) and are concentrated in a small central region of the retina called the fovea (41) . Therefore, central, highacuity color vision is mediated by cones while peripheral, lowacuity vision is mediated by rods. Night vision is predominately mediated by rods.
Both rods and cones have similar but not identical cGMPmediated phototransduction cascades. The opsins and transducins in both photoreceptors share a high degree of amino acid identity but have been found to be distinct gene products (12, 13) . Phosphodiesterases with different apparent subunit molecular masses have been found in cones and rods (15, 23) . These two isozymes share a common antigenic epitope; however, they are clearly separable by anion exchange HPLC (15, 24) . At least three CaM-dependent phosphodiesterases have been purified and characterized, one from heart and two from brain (27, (44) (45) (46) . These isozymes have subunit molecular masses of 59, 61, and 63 kD respectively. These enzymes do not cross-react with the monoclonal antibody to the photoreceptor isozymes (ROS-1) but do react to an antibody to CaM (ACC) (27, 47) . While CaM in the presence of calcium is necessary for the activation of the CaM-dependent phosphodiesterases, this activator has no effect on the photoreceptor isozymes (unpublished observation).
In this report, we have documented that the cone phosphodiesterase is functionally expressed in all six retinoblastomas and in three continuous cell lines tested. The specific activity ofthe phosphodiesterase was significantly higher in the tumor than in the cell lines suggesting that the expression of the phototransduction cascade may be reduced in cultured cells. In some ofthe cell lines, particularly those that have been in culture for long periods of time, the enzyme was not detected. The degree of apparent differentiation of the tumor as indicated by the presence of fleurettes or Flexner-Wintersteiner rosettes (1) did not correlate with the expression of the phosphodiesterase in agreement with previous analysis of retinoblastoma cell lines by northern blot with cone transducin and photopigment probes (26) .
A recent histochemical study of well-differentiated retinoblastomas using anti-rhodopsin monoclonal antibodies demonstrated that four ofthe five tumors studied stained positively with two of five of the antibodies tested (48) . The authors postulated that these well-differentiated tumors were of rod cell lineage. The results of our studies and others do not support this hypothesis. Past studies have shown that red-green photopigment mRNA but not rhodopsin mRNA was expressed in retinoblastoma (26) . Furthermore, the observation that only two ofthe anti-rhodopsin antibodies recognized epitopes on the tumors while all five recognized epitopes on normal human retina suggests that the intact rhodopsin molecule may not be expressed in retinoblastoma. Further studies will be necessary to fully understand these discrepancies.
An argument could be made that our tumors contained microscopic amounts of normal retina that accounted for our phosphodiesterase profiles. Previous studies have shown that 50% ofthe total cGMP phosphodiesterase activity in the coneenriched human fovea and > 95% ofthe activity in the peripheral human retina is of rod origin (15) . Therefore, the absence of the rod phosphodiesterase biochemically verifies the absence of normal retina in these studies.
The results showing the activation of the phototransduction cascade in the retinoblastoma cell line is intriguing. It is not currently believed that the photoreceptor contains all of the biochemical pathways necessary for photopigment recovery (49, 50) yet the data would suggest that enough photopigment remains associated with the opsin in the cells to allow transducin to exchange GDP for GTP and activate the phosphodiesterase. Several possible explanations could explain this finding. The biochemical pathways necessary for reinsertion of the photopigment into the opsin could all be present in the cells. Previous investigations have shown the presence of the interstitial retinol-binding protein in retinoblastoma (51) . A recent observation suggests that the pathways necessary for photopigment recovery are different and perhaps more complete in the cone than the rod (52), the photoreceptor where most of the investigations in photopigment regeneration have occurred. Thermodynamics suggest that enough of the chromophore could be in the correct conformation in the serum used in the culture medium even in the absence of the enzymatic regenerative pathways. Because of the tremendous amplification potential of the phototransduction cascade, only catalytic amounts of opsin are necessary for initiation of these events. Although a previous report has suggested that the presence of the chromophore is necessary for opsin to activate the cascade (53), it is possible that the cone opsin does not need the chromophore to activate transducin. Finally, another receptor could replace the opsin. This last possibility is unlikely in that other receptors have not been shown to be effective activators of transducin (54) and the activating ligands for alternate receptors were not included in the assays.
The presence of the cone-specific phototransduction cascade in retinoblastoma suggests that this tumor has biochemically differentiated along the cone cell lineage. These findings permit the development ofa unique model system to allow the study of cone phototransduction and ofthe individual components of the human cone phototransduction cascade. Conversely, further analysis of cone phototransduction may offer insight into the biology of retinoblastoma.
